NATCO Pharma NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). | Syngene International Syngene International is integrated research, development, and manufacturing company providing scientific services. | Siegfried Siegfried Holding is a company that develops and manufactures drug substances and products. | Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products. | ||
Founding Date | Founding Date 1981 | Founding Date 1993 | Founding Date 1873 | Founding Date 2003 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Hyderabad, IN HQ Central Hope Town, IN Chennai, IN Hyderabad, IN Santola, IN Vijayapuri North, IN | Locations Bangalore, IN HQ Bangalore, IN Bengaluru, IN | Locations Zofingen, CH HQ Nantong, CN Saint Vulbas, FR Hameln, DE Minden, DE Birżebbuġa, MT Barberà Del Vallès, ES see more | Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Tomsk, RU Ufa, RU | Locations Paris, FR HQ |
Employees | Employees 3,946 | Employees 6,5105% decrease | Employees 3,819 | Employees 1,56135% increase | Employees 7517% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) ₹40b (FY, 2024) | Revenue (est.) ₹33.7b (FY, 2024) | Revenue (est.) CHF1.3b (FY, 2023) | Revenue (est.) ₽142.9b (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods ₹7.2b (FY, 2024) | Cost of goods ₹9.3b (FY, 2024) | Cost of goods CHF869.7m (FY, 2023) | Cost of goods ₽109.3b (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit ₹34.1b (FY, 2024) | Gross profit ₹25.6b (FY, 2024) | Gross profit CHF406.7m (FY, 2023) | Gross profit ₽33.6b (FY, 2023) | Gross profit N/A |
Net income | Net income ₹13.9b (FY, 2024) | Net income ₹5.1b (FY, 2024) | Net income CHF112.7m (FY, 2023) | Net income ₽23.3b (FY, 2023) | Net income N/A |